FR2472387A1 - Compositions pharmaceutiques pour le traitement de l'oedeme pulmonaire aigu, de certains etats de choc et de l'hyperfibrinolyse - Google Patents

Compositions pharmaceutiques pour le traitement de l'oedeme pulmonaire aigu, de certains etats de choc et de l'hyperfibrinolyse Download PDF

Info

Publication number
FR2472387A1
FR2472387A1 FR8027469A FR8027469A FR2472387A1 FR 2472387 A1 FR2472387 A1 FR 2472387A1 FR 8027469 A FR8027469 A FR 8027469A FR 8027469 A FR8027469 A FR 8027469A FR 2472387 A1 FR2472387 A1 FR 2472387A1
Authority
FR
France
Prior art keywords
arginine
hyperfibrinolysis
pulmonary edema
animals
caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8027469A
Other languages
English (en)
French (fr)
Other versions
FR2472387B1 (enExample
Inventor
Giancarlo Sportoletti
Alessandro Baglioni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Publication of FR2472387A1 publication Critical patent/FR2472387A1/fr
Application granted granted Critical
Publication of FR2472387B1 publication Critical patent/FR2472387B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR8027469A 1979-12-28 1980-12-24 Compositions pharmaceutiques pour le traitement de l'oedeme pulmonaire aigu, de certains etats de choc et de l'hyperfibrinolyse Granted FR2472387A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT28416/79A IT1127321B (it) 1979-12-28 1979-12-28 Composizione farmaceutiche aventi specifiche proprieta' terapeutiche nei confronti dell'edema polmonare acuto,di alcuni stati di shock e dell'iperfibrinolisi

Publications (2)

Publication Number Publication Date
FR2472387A1 true FR2472387A1 (fr) 1981-07-03
FR2472387B1 FR2472387B1 (enExample) 1983-10-07

Family

ID=11223557

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8027469A Granted FR2472387A1 (fr) 1979-12-28 1980-12-24 Compositions pharmaceutiques pour le traitement de l'oedeme pulmonaire aigu, de certains etats de choc et de l'hyperfibrinolyse

Country Status (24)

Country Link
US (2) US4308280A (enExample)
JP (1) JPS56100717A (enExample)
AR (1) AR227297A1 (enExample)
AU (1) AU529650B2 (enExample)
BE (1) BE886759A (enExample)
BR (1) BR8008492A (enExample)
CA (1) CA1166160A (enExample)
DE (1) DE3027056A1 (enExample)
DK (1) DK523980A (enExample)
ES (1) ES497509A0 (enExample)
FI (1) FI803995A7 (enExample)
FR (1) FR2472387A1 (enExample)
GB (1) GB2066073B (enExample)
GR (1) GR72834B (enExample)
IE (1) IE50550B1 (enExample)
IN (1) IN151731B (enExample)
IT (1) IT1127321B (enExample)
LU (1) LU83028A1 (enExample)
NL (1) NL8006706A (enExample)
NO (1) NO803918L (enExample)
PH (1) PH16250A (enExample)
PT (1) PT72273B (enExample)
SE (1) SE8009102L (enExample)
ZA (1) ZA807514B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112805A (en) * 1985-11-22 1992-05-12 Labsystems, Oy Pharmaceutical preparation for promoting epithelial healing and prevention of epithelial destruction
IT1201511B (it) * 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
SE468881B (sv) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
US5436270A (en) * 1993-04-07 1995-07-25 National Science Council Method for protecting against endotoxin-induced shock
US6613358B2 (en) 1998-03-18 2003-09-02 Theodore W. Randolph Sustained-release composition including amorphous polymer
US20050148669A1 (en) * 2004-10-21 2005-07-07 Daniel Amato Amino acid esters as nutrient supplements and methods of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR617M (enExample) * 1959-05-08 1961-06-19

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS514125A (en) * 1974-06-27 1976-01-14 Mitsubishi Chem Ind N22 ashiru ll arugininesuterumatahasono sanfukaenno seizoho

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR617M (enExample) * 1959-05-08 1961-06-19

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EXBK/66 *
EXBK/76 *

Also Published As

Publication number Publication date
GB2066073B (en) 1984-02-01
JPS56100717A (en) 1981-08-12
FI803995L (fi) 1981-06-29
AR227297A1 (es) 1982-10-15
IE802606L (en) 1981-06-28
ZA807514B (en) 1981-11-25
IE50550B1 (en) 1986-05-14
SE8009102L (sv) 1981-06-29
AU6502880A (en) 1981-07-02
BE886759A (nl) 1981-04-16
GB2066073A (en) 1981-07-08
IT1127321B (it) 1986-05-21
FR2472387B1 (enExample) 1983-10-07
AU529650B2 (en) 1983-06-16
NO803918L (no) 1981-06-29
DE3027056A1 (de) 1981-07-02
FI803995A7 (fi) 1981-06-29
PT72273A (en) 1981-01-01
JPS6342603B2 (enExample) 1988-08-24
LU83028A1 (de) 1981-03-27
BR8008492A (pt) 1981-07-14
PT72273B (en) 1981-11-05
US4405643A (en) 1983-09-20
GR72834B (enExample) 1983-12-07
IT7928416A0 (it) 1979-12-28
IN151731B (enExample) 1983-07-16
CA1166160A (en) 1984-04-24
ES8205394A1 (es) 1982-06-16
NL8006706A (nl) 1981-07-16
US4308280A (en) 1981-12-29
DK523980A (da) 1981-06-29
ES497509A0 (es) 1982-06-16
PH16250A (en) 1983-08-16

Similar Documents

Publication Publication Date Title
CA1203242A (fr) Procede de preparation de sels derives de l'acide 3- hydroxybutanoique et d'une base organique aminee, et les sels ainsi obtenus
EP0072726B1 (fr) Composés aminés dérivés de la pyridazine actifs sur le système nerveux central
FR2472387A1 (fr) Compositions pharmaceutiques pour le traitement de l'oedeme pulmonaire aigu, de certains etats de choc et de l'hyperfibrinolyse
CH670448A5 (enExample)
FR2521134A1 (fr) Urees et thio-urees substituees, leur procede de preparation et leur application therapeutique comme medicaments anti-atherosclereux
EP0068998A1 (fr) Aryl-1 aminométhyl-2 cyclopropanes carboxylates (Z), leur préparation et leur application en tant que médicaments utiles dans le traitement d'algies diverses
EP0133176B1 (fr) Composition pharmaceutique ou vétérinaire destinée à combattre des troubles ischémiques cardiaques
EP0262053A2 (fr) Nouveaux dérivés d'amino-acides, leur procédé de préparation et compositions pharmaceutiques les contenant
LU83739A1 (fr) Alpha-(3,4,5-trimethoxybenzoylthio)propionylglycine,son procede de preparation et compositions pharmaceutiques la contenant
EP0173597B1 (fr) Nouveaux éther-oxydes dérivés de cyclopropylphénols
EP0135432B1 (fr) Dérivés de l'acide benzoique, procédé de préparation et application à titre de médicaments désinfectants ou de conservateurs
LU83307A1 (fr) Derives d'adenosine a activite anti-inflammatoire et analgesique,ainsi que des compositions therapeutiques contenant ces derives comme principe actif
FR2455590A1 (fr) Nouveaux derives d'acide 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoique, utiles notamment comme agents bloquants des recepteurs a- et b-adrenergiques, et leur procede de preparation
US4720379A (en) Use of dimercaptopropanesulfonic acid and dimercapto-propanesuccinic acid for the preparation of pharmaceutical compositions and a method of treatment
EP0092287B1 (fr) Sels d'acétylcystéine, leur préparation et leur utilisation
JPH06107539A (ja) チロシナーゼ阻害剤
FR2559771A1 (fr) Derives de la 3-pyrrolidinopropiophenone et procede pour leur preparation
FR2470110A1 (fr) Derives de la decrapenylamine, leurs sels acides d'addition et composition pharmaceutique renfermant ces produits
WO1981002295A1 (fr) Phenoxyisobutyrates de moroxydine et medicaments les contenant
CH630803A5 (en) Medicinal preparations, for the treatment of hypercholesterolaemia in particular
EP0244318B1 (fr) Nouveaux dérivés de la N-[(triméthoxy-2,4,6-benzoyl)-3 propyl] pipéridine, leurs procédés de préparation et leur application en thérapeutique
EP0035945B1 (fr) Nouvelles guanidines acylées, urées et urées substituées, leur procédé de fabrication et leur application en tant que médicaments
FR2763842A1 (fr) Compositions cosmetiques ou dermopharmaceutiques contenant des derives de threonine ou de serine
CH624922A5 (en) Process for the preparation of new methylamine derivatives
EP0174888B1 (fr) Dérivés de 1-(aminophényl)-2-amino-éthanone, procédé de préparation et utilisation en thérapeutique

Legal Events

Date Code Title Description
ST Notification of lapse